PMV Pharmaceuticals (NASDAQ:PMVP – Free Report) had its price target lowered by HC Wainwright from $35.00 to $29.00 in a research report sent to investors on Friday morning, Marketbeat Ratings reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for PMV Pharmaceuticals’ FY2024 earnings at ($2.02) EPS. PMV […]